KEY FINDINGS
The global advanced wound care management market is projected to develop with a CAGR of 11.63% during the forecasted period of 2021 to 2028. The market growth is supplemented by key factors such as the surging aging population, technological advancements, and the increasing prevalence of chronic conditions.
MARKET INSIGHTS
Advanced wound care entails products used to treat chronic and acute wounds, including burns, ulcers, and postoperative wounds. Advanced wound care products such as hydrocolloids, hydrogels, film and foam dressings, as well as alginates, ensure that the injury is hydrated in order to facilitate rapid healing. Advanced wound care products offer solutions to patients suffering from chronic wounds by providing reasonably priced and readily accessible products.
As per the data issued by the World Population Prospects: the 2019 Revision, by 2050, one in six people across the globe will be over the age of 65, indicating an increase from one in 11 in 2019. By 2050, one in four individuals residing in Europe and Northern America are expected to be aged 65 or above. Moreover, the life expectancy in the majority of countries worldwide surged tremendously. The improvement in life expectancy is primarily accredited to the significant advancements in diagnostic technology and medical science, in addition to the augmenting awareness in terms of hygiene, health, and nutrition. As a result, the demand for improved treatment facilities with an early diagnosis of chronic conditions plays a vital role in propelling the global advanced wound care management market growth.
REGIONAL INSIGHTS
The global advanced wound care management market growth assessment is analyzed across the Asia-Pacific, Europe, North America, and the Rest of World. The Asia-Pacific is set to grow with the highest CAGR over the forecasted period. The region’s market growth is credited to the increasing incidence of chronic diseases, the growing patient awareness regarding advanced wound care products, and the high disposable incomes.
COMPETITIVE INSIGHTS
While the competition among existing players is intense, the price pressure among vendors has continued to increase. Despite the high number of market participants, the majority of the revenue share is controlled only by a few participants. Some of the key firms operating in the global market are 3M Company, Johnson & Johnson (Ethicon Inc), Medline Industries Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING AGING POPULATION
3.1.2. INCIDENCE OF CHRONIC DISEASES
3.1.3. ADVANCEMENT IN TECHNOLOGY
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF ADVANCED WOUND CARE PRODUCTS
3.2.2. LACK OF TRAINED PROFESSIONALS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON ADVANCED WOUND CARE MANAGEMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY PRODUCT
5.1. THERAPY DEVICES
5.1.1. NEGATIVE PRESSURE WOUND THERAPY DEVICES (NPWT)
5.1.2. OXYGEN AND HYPERBARIC OXYGEN EQUIPMENT
5.1.3. ELECTROMAGNETIC THERAPY DEVICES
5.1.4. OTHER THERAPY DEVICES
5.2. EXUDATE MANAGEMENT
5.2.1. FOAM DRESSINGS
5.2.2. HYDROCOLLOID DRESSINGS
5.2.3. ALGINATE DRESSINGS
5.2.4. HYDROGEL DRESSINGS
5.3. INFECTION MANAGEMENT
5.3.1. COLLAGENS
5.3.2. SILVER DRESSINGS
5.3.3. NON-SILVER DRESSINGS
5.4. ACTIVE WOUND CARE
5.4.1. SKIN SUBSTITUTES
5.4.2. GROWTH FACTORS
6. MARKET BY APPLICATION
6.1. CHRONIC WOUNDS
6.1.1. VENOUS LEG ULCERS
6.1.2. DIABETIC FOOT ULCERS
6.1.3. PRESSURE ULCERS
6.1.4. ARTERIAL ULCERS
6.2. ACUTE WOUNDS
6.2.1. BURNS AND TRAUMA
6.2.2. SURGICAL WOUNDS
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. COMMUNITY HEALTH SERVICE CENTERS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.2. CANADA
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. KEY GROWTH ENABLERS
8.2.3. KEY CHALLENGES
8.2.4. KEY PLAYERS
8.2.5. COUNTRY ANALYSIS
8.2.5.1. GERMANY
8.2.5.2. FRANCE
8.2.5.3. UNITED KINGDOM
8.2.5.4. ITALY
8.2.5.5. RUSSIA
8.2.5.6. BELGIUM
8.2.5.7. POLAND
8.2.5.8. REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. KEY GROWTH ENABLERS
8.3.3. KEY CHALLENGES
8.3.4. KEY PLAYERS
8.3.5. COUNTRY ANALYSIS
8.3.5.1. CHINA
8.3.5.2. JAPAN
8.3.5.3. INDIA
8.3.5.4. AUSTRALIA & NEW ZEALAND
8.3.5.5. SOUTH KOREA
8.3.5.6. THAILAND
8.3.5.7. INDONESIA
8.3.5.8. VIETNAM
8.3.5.9. REST OF ASIA-PACIFIC
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. KEY GROWTH ENABLERS
8.4.3. KEY CHALLENGES
8.4.4. KEY PLAYERS
8.4.5. REGIONAL ANALYSIS
8.4.5.1. LATIN AMERICA
8.4.5.2. MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. 3M COMPANY
9.2.2. B BRAUN MELSUNGEN AG
9.2.3. COLOPLAST
9.2.4. CONVATEC GROUP PLC
9.2.5. ESSITY AB
9.2.6. HARTMANN GROUP
9.2.7. HOLLISTER INCORPORATED
9.2.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9.2.9. JOHNSON & JOHNSON (ETHICON INC)
9.2.10. MEDTRONIC PLC
9.2.11. MEDLINE INDUSTRIES INC
9.2.12. MOLNLYCKE HEALTH CARE AB
9.2.13. ORGANOGENESIS HOLDINGS INC
9.2.14. SMITH & NEPHEW PLC
1. 3M COMPANY
2. B BRAUN MELSUNGEN AG
3. COLOPLAST
4. CONVATEC GROUP PLC
5. ESSITY AB
6. HARTMANN GROUP
7. HOLLISTER INCORPORATED
8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9. JOHNSON & JOHNSON (ETHICON INC)
10. MEDTRONIC PLC
11. MEDLINE INDUSTRIES INC
12. MOLNLYCKE HEALTH CARE AB
13. ORGANOGENESIS HOLDINGS INC
14. SMITH & NEPHEW PLC
